Evaluation of α-Globin Gene Mutations Among Different Ethnic Groups in Khuzestan Province, Southwest Iran

References

• Galanello R, Cao A. α-Thalassemia. Genet Med. 2011;13(2):83–88
   PubMed Web of Science ®Google Scholar
• Vichinsky EP. α Thalassemia major – New mutations, intrauterine management, and outcomes. Hematology Am Soc Hematol Educ Program. 2009;2009(1):35–41
   Google Scholar
• Alkindi SS, AlZadjali S, Daar S, et al. A stepwise α-thalassemia screening strategy in high-prevalence areas. Eur J Haematol. 2013;91(2):164–169
   PubMed Web of Science ®Google Scholar
• Mahajan MC, Karmakar S, Newburger, et al. Dynamics of α-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34+ cells in culture. Exper Hematol. 2009;37(10):1143–1156
   PubMed Web of Science ®Google Scholar
• Vichinsky E. Advances in the treatment of α-thalassemia. Blood Rev. 2012;26(Suppl 1):S31–S34
   PubMed Web of Science ®Google Scholar
• Pornprasert S, Prasing W. Detection of α0 thalassemia South-East Asian type deletion by droplet digital PCR. Eur J Haematol. 2014;92(3):244–248
   PubMed Web of Science ®Google Scholar
• Akhavan-Niaki H, Kamangari RY, Banihashemi A, et al. Hematologic features of α thalassemia carriers. Int J Molec Cell Med. 2012;1(3):162–167
   PubMedGoogle Scholar
• Alcoforado GHdM, Bezerra CM, Lemos TMAM, et al. Prevalence of α-thalassemia 3.7 kb deletion in the adult population of Rio Grande do Norte, Brazil. Genet Molec Biol. 2012;35(3):594–598
   PubMed Web of Science ®Google Scholar
• Hafezi-Nejad N, Khosravi M, Bayat N, et al. Characterizing a cohort of α-thalassemia couples collected during screening for hemoglobinopathies: 14 Years of an Iranian experience. Hemoglobin. 2014;38(3):153–157
   PubMed Web of Science ®Google Scholar
• Miri M, Tabrizi Namini M, Hadipour Dehshal M, et al Thalassemia in Iran in last twenty years: The carrier rates and the births trend. Iranian J Blood Cancer. 2013;6(1):11–17
   Google Scholar
• Miri-Moghaddam E, Motaharitabar E, Erfannia L, et al. High school knowledge and attitudes towards thalassemia in Southeastern Iran. Int J Hematol-Oncol Stem Cell Res. 2014;8(1):24–30
   PubMedGoogle Scholar
• Saleh-Gohari N, Bami MK, Nikbakht R, Karimi-Maleh H. Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers. J Clin Pathol. 2015;68(7):562–566
   PubMed Web of Science ®Google Scholar
• Akbari H, Majdzadeh R, Foroushani AR, Raeisi A. Timeliness of malaria surveillance system in iran. Iranian J Public Health. 2013;42(1):39–47
   PubMed Web of Science ®Google Scholar
• Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: Epidemiology, prevention, and management. J Pediatr Hematol/Oncol. 2007;29(4):233–238
   PubMed Web of Science ®Google Scholar
• Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215
   PubMed Web of Science ®Google Scholar
• Liu Y, Old J, Miles K, et al. Rapid detection of α-thalassaemia deletions and α-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108(2):295–299
   PubMed Web of Science ®Google Scholar
• Saleh-Gohari N, Khosravi-Mashizi A. Spectrum of α-globin gene mutations in the Kerman Province of Iran. Hemoglobin. 2010;34(5):451–460
   PubMed Web of Science ®Google Scholar
• Karamzade A, Mirzapour H, Hoseinzade M, et al. α-Globin gene mutations in Isfahan Province, Iran. Hemoglobin. 2014;38(3):161–164
   PubMed Web of Science ®Google Scholar
• Zandian K, Nateghi J, Keikhaie B, et al. α-Thalassemia mutations in Khuzestan Province, Southwest Iran. Hemoglobin. 2008;32(6):546–552
   PubMed Web of Science ®Google Scholar
• Hadavi V, Jafroodi M, Hafezi-Nejad N, et al. α-Thalassemia mutations in Gilan Province, North Iran. Hemoglobin. 2009;33(3–4):235–241
   PubMed Web of Science ®Google Scholar
• Tamaddoni A, Hadavi V, Nejad NH, et al. α-Thalassemia mutation analyses in Mazandaran province, North Iran. Hemoglobin. 2009;33(2):115–123
   PubMed Web of Science ®Google Scholar
• Sarookhani MR, Asiabanha M. Spectrum of α-thalassemia mutations in Qazvin Province, Iran. African J Biotechnol. 2013;10(77):17690–17694
   Google Scholar
• Dehbozorgian J, Moghadam M, Daryanoush S, et al. Distribution of α-thalassemia mutations in Iranian population. Hematology. 2015;20(6):359–362
   PubMed Web of Science ®Google Scholar
• Hellani A, Fadel E, El-Sadadi S, et al. Molecular spectrum of α-thalassemia mutations in microcytic hypochromic anemia patients from Saudi Arabia. Genet Test Molec Biomarkers. 2009;13(2):219–221
   PubMed Web of Science ®Google Scholar
• Farra C, Badra R, Fares F, et al. α Thalassemia allelic frequency in Lebanon. Pediatr Blood Cancer. 2015;62(1):120–122
   PubMed Web of Science ®Google Scholar
• Wajcman H, Blouquit Y, Gombaud-Saintonge G, et al. Hb Fontainebleau [α21(B2)Ala→Pro], a new silent mutant hemoglobin. Hemoglobin. 1989;13(5):421–428
   PubMed Web of Science ®Google Scholar
• Upadhye DS, Jain D, Nair SB, et al. First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders. J Clin Pathol. 2012;65(7):654–659
   PubMed Web of Science ®Google Scholar
• Mashon RS, Nair S, Sawant P, et al. Hemoglobin Fontainebleau [α21(B2)Ala→Pro]: The second report from India. Indian J Hum Genet. 2013;19(3):352–354
   PubMedGoogle Scholar
• Kyrri AR, Felekis X, Kalogerou E, et al. Hemoglobin variants in Cyprus. Hemoglobin. 2009;33(2):81–94
   PubMed Web of Science ®Google Scholar
• Brennan SO, Chan T, Ryken S, Ruskova A. A second case of Hb Fontainebleau [α21(B2)Ala→Pro] in an individual with microcytosis. Hemoglobin. 2009;33(3–4):258–261
   PubMed Web of Science ®Google Scholar
• Nillakupt K, Nathalang O, Arnutti P, et al. Prevalence and hematological parameters of thalassemia in Tha Kradarn subdistrict Chachoengsao Province, Thailand. J Med Assoc Thai. 2012;95(Suppl 5):S124–S132
   Google Scholar